Abstract
A comparison of clofazimine and dapsone in the management of untreated lepromatous leprosy showed no significant differences between the two drugs in terms of morphological and bacterial indices. The incidence of erythema nodosum leprosum was similar in the two groups. Since dapsone is cheaper than clofazimine it remains the drug of choice for the routine management of untreated lepromatous leprosy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BROWNE S. G., HOGERZEIL L. M. "B 663" in the treatment of leprosy. Preliminary report of a pilot trial. Lepr Rev. 1962 Jan;33:6–10. [PubMed] [Google Scholar]
- BROWNE S. G. TREATMENT OF LEPROSY WITH B 663 APPRAISAL OF THE PILOT TRIAL AFTER THREE YEARS. Lepr Rev. 1965 Jan;36:13–15. doi: 10.5935/0305-7518.19650004. [DOI] [PubMed] [Google Scholar]
- Karat A. B., Jeevaratnam A., Karat S., Rao P. S. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy. Br Med J. 1970 Jan 24;1(5690):198–200. doi: 10.1136/bmj.1.5690.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pettit J. H., Rees R. J., Ridley D. S. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1967 Jan-Mar;35(1):25–33. [PubMed] [Google Scholar]
- Public Health Weekly Reports for NOVEMBER 26, 1943. Public Health Rep. 1943 Nov 26;58(48):1729–1760. [PMC free article] [PubMed] [Google Scholar]
- SHEPARD C. C., MCRAE D. H. MYCOBACTERIUM LEPRAE IN MICE: MINIMAL INFECTIOUS DOSE, RELATIONSHIP BETWEEN STAINING QUALITY AND INFECTIVITY, AND EFFECT OF CORTISONE. J Bacteriol. 1965 Feb;89:365–372. doi: 10.1128/jb.89.2.365-372.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams T. W., Jr, Mott P. D., Wertlake P. T., Rubio J. B., Adler R. C., Hill G. J., 2nd, Suarez G. P., Knight V. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy. Int J Lepr. 1965 Jul-Sep;33(3 Suppl):767–777. [PubMed] [Google Scholar]